Hematopoietic Stem Cell Transplantation (HSCT) Market: Allogeneic transplant is projected to continue to hold a dominant market share – BioSpace

Global Hematopoietic Stem Cell Transplantation Market: Overview

Hematopoietic stem cells (HSCs) are present in the bone marrow and blood. They are also known as hematopoietic progenitor cells (HPCs). Hematopoietic stem cells are capable of producing mature blood cells, such as platelets, white blood cells, and red blood cells. These cells are used in the treatment of different types of malignant diseases (e.g. lymphoma, leukemia) and non-malignant (e.g. hemoglobinopathies, bone marrow failure) to rebuild or replace a patient's hematopoietic system. This type of treatment is known as stem cell transplant or bone marrow transplant. Hematopoietic stem cells have also been used in clinical trials with U.S. FDA oversight for the treatment of genetic diseases, autoimmune diseases, and other indications. Over the last 30 years, the hematopoietic stem cells transplantation market has seen a rapid and constant expansion with advancements in lifesaving technologies. Hematopoietic stem cell transplantation brings about restoration of the patients medullary and immune function while treating a diverse range of about 70 non-hematological and hematological disorders. Overall, hematopoietic stem cells transplantation is used in the treatment of immunological, oncological, non-malignant, hematological, malignant, and hereditary diseases.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=62316

There are two types of stem cell transplants: allogeneic and autologous. Allogeneic HSCT involves the replacement of diseased or damaged cells with cells from a healthy donor. The donors tissue type needs to match the receivers tissue type as closely as possible to help prevent the risk of problems with the transplant. Allogeneic transplantation is used for therapeutic intervention of patients with hematological disorders (cancerous or non-cancerous). Autologous HSCT replaces diseased or damaged cells with the patients own stem cells. Harvesting of a patients stem cells is done before chemotherapy, and harvested stem cells are then transplanted back into the patient after treatment. Based on the source of hematopoietic stem cells, there are three types of HSCTs: cord blood transplant, peripheral blood stem cell transplant, and bone marrow transplant (BMT).

Request for Analysis of COVID-19 Impact on Hematopoietic Stem Cell Transplantation (HSCT) Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=62316

Global Hematopoietic Stem Cell Transplantation Market: Key Trends

The global hematopoietic stem cell transplantation market is expected to expand at a rapid pace, due to a rise in the prevalence of hematopoietic disorders, increase in success rates of transplantation, and increase in the aging population across the world. According to a research report by the Scientific America, transplantation rates over the globe have increased from 50,000 HSC transplants per year in 2012 to 75,000 HSC transplants per year in 2015. However, high cost of transplantation and lack of funding for organizations such as the Worldwide Network for Blood & Marrow Transplantation (WBMT) are expected to restrain the global hematopoietic stem cell transplantation market during forecast period.

Pre book Hematopoietic Stem Cell Transplantation (HSCT) Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=62316&ltype=S

Global Hematopoietic Stem Cell Transplantation Market: Segmentation

The global hematopoietic stem cell transplantation market can be segmented based on disease indication, transplant, application, and region. In terms of disease indication, the market can be classified into leukemia, lymphoproliferative disorders, and non-malignant disorders. Based on transplant, the global hematopoietic stem cell transplantation market can be categorized into autologous and allogeneic. Allogeneic transplant is projected to continue to hold a dominant market share in terms of revenue during the forecast period, due to the high average cost of allogeneic transplants as compared to that of autologous transplants. In terms of application, the market can be segmented into cord blood transplants, peripheral blood stem cells transplants, and bone marrow transplants.

Top of Form

Ask for Discount :

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=62316

Global Hematopoietic Stem Cell Transplantation Market: Regional Analysis

Based on region, the global hematopoietic stem cell transplantation market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Europe is projected to lead the global market during the forecast period. The regions dominance is attributed to the overall increase in success rate of transplants, easy technological applications, and high income of the population.

Global Hematopoietic Stem Cell Transplantation Market: Competitive Landscape

Key players operating in the global hematopoietic stem cell transplantation market include Escape Therapeutics, Lonza Group, Regen BioPharma Inc, Cesca Therapeutics Inc., Cryo-Save AG, CBR Systems, Inc., Pluristem Therapeutics Inc., China Cord Blood Corporation, and ViaCord Inc.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Mr. Rohit BhiseyTransparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

Read the original post:

Hematopoietic Stem Cell Transplantation (HSCT) Market: Allogeneic transplant is projected to continue to hold a dominant market share - BioSpace